Send feedback

EP300 p.Pro11Ser

c.31C>T · rs762278198 · VCV2195143

Conflicting classifications of pathogenicity Conflicting submitters
Classification
Conflicting classifications of pathogenicity
ClinVar
Review
Conflicting submitters ★☆☆☆
ClinVar · 2 submitters
AlphaMissense
likely benign
0.1353 · ACMG-weighted
gnomAD v4.1
Rare
ultra-rare (popmax 0.0107%, afr)
Missense predictors
0/2 damaging
AlphaMissense, SaProt · REVEL indeterminate
Conditions
2
EP300-related disorder

Computational evidence

Protein change
AlphaMissense0.1353likely benign
REVEL0.402indeterminate
SaProtLLR -8.38tolerated
⇒ AlphaMissense and SaProt both call this tolerated; REVEL is indeterminate.
Splicing
SpliceAI—not assessed · no allele here is in the release
Constraint at this position
ConservationphyloP 5.7GERP 1.8, phastCons 1
Regional constrainto/e 0.96unconstrained · MANE · 35 kb · p 0.42 · regional, not allelic
Overall
CADD23.5PHRED · no single calibrated threshold — expert panels disagree

AlphaMissense carries the ACMG weight for missense; REVEL and SaProt are independent agreement signals.

Population frequency

gnomAD v4.1 · exomes + genomes
Grpmax group 0.0107% African / African-American · 8/74,932 alleles
Filtering AF 0.00528% ClinGen BA1/BS1 input FAF95, joint · FAF99 0.00381%
Overall 0.00273% 44/1,614,040 alleles · ultra-rare exomes 36/1,461,842 · genomes 8/152,198 · joint denominator
Ancestry group Frequency 1 in
African / African-Americangrpmax 0.0107% 9,367
Remaining individualsnot grpmax-eligible 0.0064% 15,620
European (non-Finnish) 0.00271% 36,876

Rarity supports pathogenicity (ACMG PM2); frequency above a disease-specific BA1/BS1 threshold argues against it. A variant frequent in one ancestry group can be near-absent in others, so a single global figure can mislead.

Variant & gene context

Gene
EP300
Protein
p.Pro11Ser
Coding
c.31C>T
MANE Select
NM_001429
dbSNP
rs762278198
Type
single nucleotide variant
Location
chr22:41093035 (GRCh38)
Gene constraint
LOEUF 0.164 · pLI 1.00 · ClinGen HI 3/3 (gnomAD)
Structure
AlphaFold pLDDT 54.88 · 60 PDB
Residue 11
the 'interaction with alx1' region; the 'disordered' region; the 'interaction with rora' region
Full EP300 gene report on Sugi Atlas → Gene function, pathways, protein structure, interactions & more

Disease context

EP300-related disorder

Also linked: Rubinstein-Taybi syndrome due to EP300 haploinsufficiency

Similar variants

Built on 18 open, versioned datasets — ClinVar, gnomAD, AlphaMissense, REVEL, ClinGen & more — plus Sugi Variant's own cross-source analysis. Source data 2026-01–2026-10, ClinVar 2026-10. Full sources & versions →

Cite Sugi Variant

Gür T. Sugi Variant: A Deterministic Per-Variant Germline Reference from a Knowledge Graph for Humans and AI Agents. 2026. doi:10.5281/zenodo.21509445. This variant: https://sugi.bio/variant/ep300-p-pro11ser (accessed [today's date]).

Preprint & method: sugi.bio/variant/method Machine-readable: this page as Markdown